Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07429396Not Yet Recruiting

Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction

Role: collaborator

NCT07100535Not ApplicableActive Not Recruiting

Education and Literacy for an Active Life (Educação e Literacia Para Uma Vida Ativa)

Role: collaborator

NCT04370808Completed

VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection

Role: collaborator

All 3 trials loaded